Sorry, you need to enable JavaScript to visit this website.

TIKOSYN® (dofetilide) Boxed Warning

To minimize the risk of induced arrhythmia, patients initiated or re-initiated on TIKOSYN should be placed for a minimum of 3 days in a facility that can provide calculations of creatinine clearance, continuous electrocardiographic monitoring, and cardiac resuscitation. For detailed instructions regarding dose selection, see DOSAGE AND ADMINISTRATION.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No